4//SEC Filing
NEOGENOMICS INC 4
Accession 0001209191-16-117182
$NEOCIK 0001077183operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 8:43 PM ET
Size
11.9 KB
Accession
0001209191-16-117182
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-04-20$7.15/sh+100,000$715,000→ 100,000 totalExercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying)
Holdings
- 55,953
Common Stock
- 10,000
Stock Option (Right to Buy)
Exercise: $3.76From: 2014-04-16Exp: 2018-04-16→ Common Stock (10,000 underlying) - 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $1.69From: 2012-04-12Exp: 2017-04-12→ Common Stock (10,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]On April 12, 2012 Dr.Brodie was granted 10,000 stock options. There was immediate vesting of 2,500 shares and then 2,500 shares will vest on the next three anniversary dates of the grant date.
- [F2]On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant dates.
- [F3]On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F4]On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F5]On April 20, 2016, Mr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001077183
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 8:43 PM ET
- Size
- 11.9 KB